Literature DB >> 26037202

Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice.

Anna Motterle1, Sonia Gattesco, Dorothée Caille, Paolo Meda, Romano Regazzi.   

Abstract

AIMS/HYPOTHESIS: Exposure of pancreatic beta cells to cytokines released by islet-infiltrating immune cells induces alterations in gene expression, leading to impaired insulin secretion and apoptosis in the initial phases of type 1 diabetes. Long non-coding RNAs (lncRNAs) are a new class of transcripts participating in the development of many diseases. As little is known about their role in insulin-secreting cells, this study aimed to evaluate their contribution to beta cell dysfunction.
METHODS: The expression of lncRNAs was determined by microarray in the MIN6 beta cell line exposed to proinflammatory cytokines. The changes induced by cytokines were further assessed by real-time PCR in islets of control and NOD mice. The involvement of selected lncRNAs modified by cytokines was assessed after their overexpression in MIN6 cells and primary islet cells.
RESULTS: MIN6 cells were found to express a large number of lncRNAs, many of which were modified by cytokine treatment. The changes in the level of selected lncRNAs were confirmed in mouse islets and an increase in these lncRNAs was also seen in prediabetic NOD mice. Overexpression of these lncRNAs in MIN6 and mouse islet cells, either alone or in combination with cytokines, favoured beta cell apoptosis without affecting insulin production or secretion. Furthermore, overexpression of lncRNA-1 promoted nuclear translocation of nuclear factor of κ light polypeptide gene enhancer in B cells 1 (NF-κB). CONCLUSIONS/
INTERPRETATION: Our study shows that lncRNAs are modulated during the development of type 1 diabetes in NOD mice, and that their overexpression sensitises beta cells to apoptosis, probably contributing to their failure during the initial phases of the disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26037202     DOI: 10.1007/s00125-015-3641-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

2.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

3.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis.

Authors:  H Heimberg; Y Heremans; C Jobin; R Leemans; A K Cardozo; M Darville; D L Eizirik
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

4.  The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.

Authors:  Divya Khaitan; Marcel E Dinger; Joseph Mazar; Joanna Crawford; Martin A Smith; John S Mattick; Ranjan J Perera
Journal:  Cancer Res       Date:  2011-05-10       Impact factor: 12.701

Review 5.  Long noncoding RNAs: cellular address codes in development and disease.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

6.  The transcriptional landscape of the mammalian genome.

Authors:  P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

7.  Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes.

Authors:  Diego Ize-Ludlow; Yaima L Lightfoot; Matthew Parker; Song Xue; Clive Wasserfall; Michael J Haller; Desmond Schatz; Dorothy J Becker; Mark A Atkinson; Clayton E Mathews
Journal:  Diabetes       Date:  2011-06-09       Impact factor: 9.461

8.  Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice.

Authors:  Elodie Roggli; Sonia Gattesco; Dorothée Caille; Claire Briet; Christian Boitard; Paolo Meda; Romano Regazzi
Journal:  Diabetes       Date:  2012-04-26       Impact factor: 9.461

9.  Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

Authors:  Elodie Roggli; Aurore Britan; Sonia Gattesco; Nathalie Lin-Marq; Amar Abderrahmani; Paolo Meda; Romano Regazzi
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

Review 10.  The genetic signatures of noncoding RNAs.

Authors:  John S Mattick
Journal:  PLoS Genet       Date:  2009-04-24       Impact factor: 5.917

View more
  27 in total

1.  Differentially Expressed Long Non-Coding RNAs Were Predicted to Be Involved in the Control of Signaling Pathways in Pediatric Astrocytoma.

Authors:  Ruth Ruiz Esparza-Garrido; Juan Manuel Rodríguez-Corona; Javier Enrique López-Aguilar; Marco Antonio Rodríguez-Florido; Ana Claudia Velázquez-Wong; Rubí Viedma-Rodríguez; Fabio Salamanca-Gómez; Miguel Ángel Velázquez-Flores
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

2.  Identification of a novel lncRNA (G3R1) regulated by GLIS3 in pancreatic β-cells.

Authors:  David W Scoville; Artiom Gruzdev; Anton M Jetten
Journal:  J Mol Endocrinol       Date:  2020-10       Impact factor: 5.098

3.  Obesity-induced reduced expression of the lncRNA ROIT impairs insulin transcription by downregulation of Nkx6.1 methylation.

Authors:  Fang Fang Zhang; Yu Hong Liu; Dan Wei Wang; Ting Sheng Liu; Yue Yang; Jia Min Guo; Yi Pan; Yan Feng Zhang; Hong Du; Ling Li; Liang Jin
Journal:  Diabetologia       Date:  2020-02-01       Impact factor: 10.122

4.  Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.

Authors:  Syamantak Majumder; Mitchell J Hadden; Karina Thieme; Sri N Batchu; Divya Niveditha; Shibasish Chowdhury; Veera Ganesh Yerra; Suzanne L Advani; Bridgit B Bowskill; Youan Liu; Hana Vakili; Tamadher A Alghamdi; Kathryn E White; Laurette Geldenhuys; Ferhan S Siddiqi; Andrew Advani
Journal:  Diabetologia       Date:  2019-08-09       Impact factor: 10.122

Review 5.  Biomarkers of β-Cell Stress and Death in Type 1 Diabetes.

Authors:  Raghavendra G Mirmira; Emily K Sims; Farooq Syed; Carmella Evans-Molina
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

6.  Signature RNAS and related regulatory roles in type 1 diabetes mellitus based on competing endogenous RNA regulatory network analysis.

Authors:  Qinghong Shi; Hanxin Yao
Journal:  BMC Med Genomics       Date:  2021-05-18       Impact factor: 3.063

7.  Involvement of circRNAs in Proinflammatory Cytokines-Mediated β-Cell Dysfunction.

Authors:  Zhen Wang; Chao Deng; Ying Zheng
Journal:  Mediators Inflamm       Date:  2021-05-04       Impact factor: 4.711

8.  Modulation and bioinformatics screening of hepatic mRNA-lncRNAs (HML) network associated with insulin resistance in prediabetic and exercised mice.

Authors:  Fatemeh Kazeminasab; Sayed Mohammad Marandi; Maryam Baharlooie; Mohammad Hossein Nasr-Esfahani; Kamran Ghaedi
Journal:  Nutr Metab (Lond)       Date:  2021-07-20       Impact factor: 4.169

Review 9.  β-Cell MicroRNAs: Small but Powerful.

Authors:  Stephen R Filios; Anath Shalev
Journal:  Diabetes       Date:  2015-11       Impact factor: 9.461

10.  Insights from lncRNAs Profiling of MIN6 Beta Cells Undergoing Inflammation.

Authors:  Chuntao Sun; Lihua Xue; Ziyang Zhu; Fan Zhang; Ruixue Yang; Xuewen Yuan; Zhanjun Jia; Qianqi Liu
Journal:  Mediators Inflamm       Date:  2016-09-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.